Nrc Health (NRC) Current Deferred Revenue (2010 - 2026)

Nrc Health has disclosed Current Deferred Revenue across 17 years of filings, most recently posting $17.2 million for Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $17.2 million, up 10.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.2 million (up 10.87% YoY), and the FY2025 annual result was $16.2 million, up 2.63% from the prior year.
• Current Deferred Revenue came in at $17.2 million for Q1 2026 at Nrc Health, up from $16.2 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $17.8 million in Q3 2025 to a low of $14.5 million in Q2 2024.
• The 5-year median for Current Deferred Revenue is $15.8 million (2024), against an average of $16.0 million.
• Across the five-year window, Current Deferred Revenue dropped 11.71% in 2022 and rose 10.87% in 2026, its largest moves.
• Nrc Health's Current Deferred Revenue stood at $15.2 million in 2022, then dropped by 2.4% to $14.8 million in 2023, then grew by 6.42% to $15.8 million in 2024, then climbed by 2.63% to $16.2 million in 2025, then advanced by 6.12% to $17.2 million in 2026.
• The last three Current Deferred Revenue figures came in at $17.2 million (Q1 2026), $16.2 million (Q4 2025), and $17.8 million (Q3 2025), per Business Quant data.